Rx IP Update - May 2017

Published date01 June 2017
Law FirmSmart & Biggar
AuthorNancy Pei,Abigail Smith
Subject MatterData Protection,Medical Devices,Patents,Life Sciences,Appeals,Damages,Judicial Review,Obviousness,Licenses,Dismissals,Health Information Technologies,Electronic Filing,Prescription Drugs,Eli Lilly,Generic Drugs,Drug Approvals,Pharmaceutical Patents,CETA,Canada,Trials,Teva Pharmaceuticals,Apotex,Mandamus Petitions,Double Patent,Supreme Court of Canada,Administrative Proceedings,Health Canada,Patented Medicines,PMNOC Regulations

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT